'New' estrogen receptor found to be key player in tamoxifen resistance

Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144564961.html">'New' estrogen receptor found to be key player in tamoxifen resistance</a></p> <p>Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug. They say the findings could provide a way to identify tamoxifen users who are no longer benefiting from the drug, allowing doctors to try another therapy option sooner.</p>